Welcome to our dedicated page for Biote news (Ticker: BTMD), a resource for investors and traders seeking the latest updates and insights on Biote stock.
Biote Corp (BTMD) delivers innovative hormone optimization solutions through its certified practitioner network. This news hub provides investors and healthcare professionals with timely updates on the company's strategic initiatives in personalized medicine and practice-building technologies.
Access authoritative coverage of Biote's latest developments including regulatory milestones, partnership announcements, and certification program expansions. Our curated news collection helps stakeholders track the company's progress in standardizing hormone therapy protocols while supporting medical practices.
Key updates include earnings reports detailing Biote's practice-building platform growth, analysis of new training modules for practitioners, and coverage of clinical advancements in personalized hormone treatments. Bookmark this page for streamlined access to operational updates and market positioning insights.
Biote reported solid financial performance in the first quarter of 2024, with revenue reaching $46.8 million, a 4.4% increase from the prior year. Procedure revenue grew by 6.6%, while the gross profit margin improved to 71.4%. The company reported a net loss of $(5.8) million, representing a net loss margin of (12.4)%. Adjusted EBITDA increased by 8.0% to $14.2 million. Biote reaffirmed its 2024 financial guidance, expecting revenue of $200-$204 million and Adjusted EBITDA of $60-$63 million.
Biote Corp. (NASDAQ: BTMD) has settled outstanding litigation with its founder, Dr. Gary S. Donovitz, by repurchasing all of his 18.4 million shares at $4.17 per share. The Settlement Agreement includes mutual claims release, termination of advisory agreement, non-compete and non-solicitation agreements, and a voting agreement. The company plans to repurchase shares over a three-year schedule for a total of approximately $76.9 million to enhance shareholder value.
FAQ
What is the current stock price of Biote (BTMD)?
What is the market cap of Biote (BTMD)?
